Decomposition of mitomycin and anthracycline cytostatics in cell culture media
- PMID: 3082277
Decomposition of mitomycin and anthracycline cytostatics in cell culture media
Abstract
The chemical stability of members of two groups of cytostatics, mitomycins and anthracyclines, has been studied in four different cell culture media enriched with serum. Stability was determined with the use of high performance liquid chromatography. In the group of mitomycins, the 7-aminomitosanes appeared to be relatively stable during a seven days incubation period at 37 degrees C when compared to the 7-methoxy congeners. The anthracycline derivatives, 4-demethoxy-daunorubicin, doxorubicin and its 4'-analogues showed half-lives of about 10-20 hours. Doxorubicinol and daunorubicin were found to be more stable. Anthracycline degradation products could be traced with the use of thin layer chromatography. All main degradation products originate from hydrolytic reactions. No enzymatic conversions could be observed. These observations may be of importance for the correct interpretation of the effects of mitomycins or anthracyclines on cells incubated in a cell culture medium.
Similar articles
-
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.J Clin Pharmacol. 1986 Sep-Oct;26(7):491-509. doi: 10.1002/j.1552-4604.1986.tb02942.x. J Clin Pharmacol. 1986. PMID: 2944917 Review.
-
[Pharmacokinetics of new anthracyclines].Bull Cancer. 1988;75(2):167-74. Bull Cancer. 1988. PMID: 3282579 Review. French.
-
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.Cancer Treat Rep. 1986 Jan;70(1):51-63. Cancer Treat Rep. 1986. PMID: 2935251 Review. No abstract available.
-
Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes.Biochem Pharmacol. 1988 Oct 15;37(20):3877-87. doi: 10.1016/0006-2952(88)90069-x. Biochem Pharmacol. 1988. PMID: 3190734
-
Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.Cancer Res. 1985 Dec;45(12 Pt 1):5995-9. Cancer Res. 1985. PMID: 3864526
Cited by
-
Exposure time versus cytotoxicity for anticancer agents.Cancer Chemother Pharmacol. 2019 Aug;84(2):359-371. doi: 10.1007/s00280-019-03863-w. Epub 2019 May 17. Cancer Chemother Pharmacol. 2019. PMID: 31102023 Free PMC article.
-
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci. 1986 Apr 25;8(2):109-33. doi: 10.1007/BF02086146. Pharm Weekbl Sci. 1986. PMID: 3520474 Review.